Sugi Predict

Sugi Predict / Compounds / SCHEMBL2702307

SCHEMBL2702307

SCHEMBL2702307

[C-]#[N+]c1ccc(NC(=O)C2(C)CC(c3ccccc3O)=NN2)cc1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ AR P10275 6/20 0.33
▸ MAPT P10636 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ CSNK1D P48730 1/20 0.33
▸ HPGD P15428 2/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ RORC P51449 2/20 0.32
▸ CXCR2 P25025 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2702408 0.92 TP53 (0.34) TP53ARMAPTLMNACSNK1D
SCHEMBL2702275 0.90 CSNK1D (0.34) TP53ARMAPTLMNACSNK1D
SCHEMBL2703411 0.86 TP53 (0.33) TP53SMN1; SMN2MAPTLMNAHTT
SCHEMBL2703645 0.85 CSNK1D (0.36) ARMAPTLMNACSNK1DKDR
SCHEMBL2701055 0.84 CSNK1D (0.38) TP53ARMAPTCSNK1DKDR
SCHEMBL2703842 0.84 TP53 (0.32) TP53ARLMNACSNK1DKDR
SCHEMBL2703438 0.84 MAPT (0.35) TP53KMT2ARAB9ASMN1; SMN2NPC1
SCHEMBL2702204 0.84 MAPT (0.36) ARMAPTLMNAGAACSNK1D
SCHEMBL2702209 0.84 MAPT (0.38) KMT2ARAB9ASMN1; SMN2NPC1AR
SCHEMBL2702526 0.84 MAPT (0.36) ARMAPTLMNAGAACSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088811-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BE) 2012-01-03 — — US disclosed
US-20100267670-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) ZHANG XUQING 2010-10-21 — — US disclosed
US-7781473-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMS) J & J Pharmaceutical Research & Development, LLC. (US) 2010-08-24 — — US disclosed
US-20090131365-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) ZHANG XUQING 2009-05-21 — — US disclosed
US-7465809-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BG) 2008-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131365-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AR, NR5A1, NR5A2 TP53 2217/4885KMT2A 1769/4885RAB9A 3036/4885
US-20100267670-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AR, NR5A1, NR5A2 TP53 2217/4885KMT2A 1769/4885RAB9A 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.